CHOP and 38 other health systems in 45 states and Washington, DC have committed to addressing racism and the public health disparities caused by racism.

Suspensions disproportionately affect low income, Black and Hispanic families and may severely limit access to employment and healthcare.

In a study published in Nature Cell Biology, CHOP researchers describe pathway and drug that could stimulate lung tissue repair in COVID patients.

The Division of Infectious Diseases continues to expand and has welcomed several new additions to our clinic team.

One of the first of its kind in the world, the CHOP Neonatology chronic lung disease program was designed to be a clinical and research home for infants with BPD receiving neonatal intensive care throughout the surrounding region and nation at large.

A new study from CHOP demonstrates that a device measuring how the pupil responds to light can show clear differences in concussions.

This year's International NASHDAY was celebrated virtually in 2020 due to COVID-19. NASHDAY raised awareness about non-alcoholic fatty liver disease (NAFLD).

Read this case study about a patient who received a liver transplant at Children’s Hospital of Philadelphia (CHOP) during COVID-19.

Using genome sequencing technology, researchers found potential causal mutations differ between ancestral groups, which may impact treatment.

After stay-at-home orders were issued, doctors at CHOP noticed a drop in the number of patients who were admitted for asthma emergencies.